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We developed a capillary electrophoresis (CE) and dispersive liquid–liquid microextraction (DLLME)
method to stereoselectively analyze hydroxyzine (HZ) and cetirizine (CTZ) in liquid culture media. The
CE analyses were performed on an uncoated fused-silica capillary; 50 mmol L1 sodium borate buffer
(pH 9.0) containing 0.8% (w/v) S-β-CD was used as the background electrolyte. The applied voltage and
temperature were +6 kV and 15 1C, respectively, and the UV detector was set to 214 nm. Chloroform
(300 mL) and ethanol (400 mL) were used as the extraction and disperser solvents, respectively, for the
DLLME. Following the formation of a cloudy solution, the samples were subjected to vortex agitation at
2000 rpm for 30 s and to centrifugation at 3000 rpm for 5 min. The recoveries ranged from 87.4 to 91.7%.
The method was linear over a concentration range of 250–12,500 ng mL1 for each HZ enantiomer
(r40.998) and 125–6250 ng mL1 for each CTZ enantiomer (r40.998). The limits of quantiﬁcation were
125 and 250 ng mL1 for CTZ and HZ, respectively. Among the six fungi studied, three species were able
to convert HZ to CTZ enantioselectively, particularly the fungus Cunninghamella elegans ATCC 10028B,
which converted 19% of (S)-HZ to (S)-CTZ with 65% enantiomeric excess.
& 2013 Elsevier B.V. All rights reserved.1. Introduction
Hydroxyzine (HZ; Fig. 1) [1] is an antihistamine drug belonging
to the piperazine class that acts by reversibly blocking histamine
H1 receptors. HZ has a chiral center and can exist in the R- or
S- form. Cytochrome P450-2D6 mediates HZ metabolism [2,3],
which results in the major carboxylated metabolite (45%) cetir-
izine (CTZ; Fig. 1) [4]. CTZ is a more potent and long-acting agent
than HZ. It is considered a second-generation histamine H1
receptor antagonist and is primarily used to treat urticaria and
allergic rhinitis. Chiral CTZ can be administered as a racemic
mixture; however, its pharmacological activity is primarily derived
from the R- enantiomer, also known as levocetirizine [5–7].ll rights reserved.
: +55 16 3602 4838.Microbial models have been used to study the biotransformation
of numerous drugs with the aim of producing their corresponding
metabolites [8–10]. Fungi, especially those belonging to the genus
Cunninghamella, have been extensively employed to mimic mamma-
lian hepatic metabolism [11]. Endophytes constitute another class
of fungi that have more recently been used in biotransformation
procedures [12]. These microorganisms spend all or part of their life
cycle colonizing the host plant healthy tissues inter- and/or intra-
cellularly, typically causing no apparent symptoms [13].
Using fungi is advantageous because they grow quickly and
easily form a multi-enzymatic system. Moreover, synthetic organic
chemists now consider biotransformation an economically viable
and competitive technology for identifying new production routes
and obtaining ﬁne chemicals, pharmaceuticals, and agrochemical
compounds [14]. In many cases, biological transformation is enantio-
selective, thus allowing researchers to produce pure enantiomers from
racemic mixtures [15].
Some papers have described the analysis of chiral HZ and/or CTZ in
different matrices. Choi et al. [16] enantioselectively characterized CTZ
Fig. 1. Chemical structures of Hydroxyzine (HZ), Cetirizine (CTZ), and Risperidone (Risp). n Represent the chiral center.
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enantioselectively characterized CTZ in guinea pig plasma, brain,
and blood microdialysis samples using HPLC with mass spectrometric
detection. Researchers have also performed chiral CTZ determination
in human plasma and in a pharmaceutical formulation by capillary
electrophoresis (CE) using sulfated-β-cyclodextrin (S-β-CD) as a chiral
selector [5,19]. To date, only one paper has described simultaneous
enantioselective HZ and CTZ characterization; in this study,
CE—maltodextrin was used as a chiral selector to facilitate the
separation of the analytes [1]. In summary, all these reported methods
relied on the use of conventional sample preparation procedures, i.e.,
protein precipitation [16–18] and liquid–liquid extraction [1,5].
In 2006, Rezaee and co-workers [20] developed a novel liquid-
phase microextraction technique termed dispersive liquid–liquid
microextraction (DLLME). This method involves appropriately
mixing the extraction and disperser solvents and injecting them
into an aqueous sample containing the target analytes to form a
cloudy solution. The surface areas between the extraction solvent
and the sample solution are initially inﬁnitely large; therefore,
the extraction equilibrium can be rapidly reached. Following the
extraction, centrifugation allows the separation of the solvent
phases; a suitable analytical method determines the enriched
analyte in the sedimented phase. This extraction technique is
attractive because it is simple, fast, inexpensive, and efﬁcient [21–24].
Recently, researchers have developed various methods using DLLME
to extract drugs and their metabolites from different biological
matrices, such as urine and plasma [25,26]. Nevertheless, the use
of DLLME in fungal biotransformation studies has never been
reported.
In light of the above considerations, and because a low-
consumption organic solvent extraction method for enantioselec-
tively measuring HZ and CTZ in biological matrices does not yet
exist, we have developed a method to couple DLLME with CE to
study enantioselective HZ fungal biotransformation.2. Materials and methods
2.1. Chemicals and reagents
The reference substances rac-hydroxyzine dihydrochloride,
rac-cetirizine dihydrochloride, and levocetirizine dihydrochloride
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Risper-
idone (Fig. 1), which was used as internal standard (I.S.), was acquired
from Toronto Research Chemicals (North York, ON, Canada). The
rac-hydroxyzine and rac-cetirizine stock solutions were prepared at
a concentration of 500 mgmL1. The rac-hydroxyzine working
solutions were prepared at concentrations of 10, 40, 80, 120, 300,
400, and 500 mgmL1, while the rac-cetirizine working solutions wereprepared at concentrations of 5, 10, 20, 50, 100, 200, and 250 mg mL1.
The I.S. solution was obtained at a concentration of 100 mgmL1. All
the solutions were prepared in methanol, stored at 20 1C, and
protected from light using amber glasses tubes.
The following solvents (HPLC grade) were used in DLLME and
in the biotransformation procedures: acetonitrile, methanol and
ethanol, purchased from JT Baker (Phillipsburg, NJ, USA); dichlor-
omethane and chloroform, obtained from Sigma (St. Louis, MO,
USA); and 1,1-dichloroethane, acquired from Fluka (Buchs, Swit-
zerland). The reagents (analytical grade) were: sodium chloride,
potassium chloride, monosodium phosphate, disodium phosphate,
magnesium sulfate, and iron sulfate, all obtained from Merck
(Darmstadt, Germany); sodium tetraborate decahydrate was
provided by JT Baker (Phillipsburg, NJ, USA). Sodium hydroxide
was purchased from Nuclear (Diadema, SP, Brazil). Potato dextrose
agar (PDA), sucrose, malt extract, dextrose, tryptone soy broth, and
yeast extract were obtained from Acumedia (Lansing, Michigan,
USA). Sulfated-β-cyclodextrin (S-β-CD) and carboxymethyl-β-
cyclodextrin (CM-β-CD) were acquired from Sigma-Aldrich (Steinheim,
Germany); hydroxypropyl-β-cyclodextrin (HP-β-CD) was provided by
Fluka (Buch, Switzerland).
The solutions used for the running buffer and in the CE rinse
cycle procedure were ﬁltered through a Millex-HV 0.45-mm disk
ﬁlter from Millipore (Bedford, MA, USA) and degassed by ultra-
sound for 5 min. Water was puriﬁed with a Milli-Q plus system
(Millipore, Bedford, MA, USA).
2.2. Capillary electrophoresis (CE)
The analyses were carried out using CE instrumentation from
Beckman Coulter Instruments, model P/ACE MDQ (Fullerton,
CA, USA). The apparatus consisted of an analyzer, an automatic
sampler with temperature control, and a diode array detector
(with the wavelength set to 214 nm for analyte detection). The
software 32 Karat™ was used to control the instrument and to
acquire data. An uncoated fused-silica capillary from Beckman
Coulter Instruments (Fullerton, CA, USA) with a 75-mm id, 30-cm
total length, and 20-cm effective length was used. Prior to its ﬁrst
use, the capillary was conditioned by rinsing with 1.0 mol L1
NaOH for 10 min at 20 1C, followed by a rinse with 0.1 mol L1
NaOH for 10 min at 20 1C and a ﬁnal water rinse for 10 min at
20 1C. At the beginning of each working day, the capillary was
rinsed with 0.1 mol L1 NaOH for 10 min, followed by a water
rinse for 10 min. Between consecutive analyses, the capillary was
rinsed with 0.1 mol L1 NaOH for 2 min, water for 2 min, and the
running buffer for 2 min. After daily use, the capillary was washed
with 0.1 mol L1 NaOH for 10 min and then with water for 10 min.
When not in use, the capillary was ﬁlled with water, and its tips
were stored immersed in water. The electrophoretic separations
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tion (pH adjusted to 9.0 with hydrochloric acid) containing S-β-CD
0.8% (w/v). All the experiments were conducted in the normal
mode. The sample injections were performed hydrodynamically at
a pressure of 0.3 psi for 5 s. The capillary and sample temperatures
were set to 15 1C. A constant voltage of +6 kV was applied during
the analyses.
2.3. Dispersive liquid–liquid microextraction (DLLME)
One-milliliter aliquots of Czapek liquid culture medium spiked
with 50 mL of HZ and CTZ at a concentration of 200 μg mL1 or
samples obtained in the biotransformation process were trans-
ferred to 10-mL conical glass tubes and buffered with 1 mL of
0.25 mol L1 dibasic phosphate buffer solution at pH 7.5. Subse-
quently, a mixture of 400 mL of ethanol (disperser solvent) and
300 mL of chloroform (extraction solvent) was rapidly injected
into the sample using a 1-mL microsyringe; a cloudy solution
then formed in the conical glass tube. Immediately afterward, the
samples were vigorously shaken by vortex agitation at 2000 rpm
for 30 s. Next, the samples were centrifuged at 3000 rpm for
5 min, and the extraction solvent was sedimented at the bottom of
the conical glass tube. Following the centrifugation, 250 mL of the
sedimented phase was transferred to another conical glass tube
using a microsyringe. The extract was then evaporated to dryness
under compressed air stream. The dried residue was reconstituted
in 120 mL of water and injected into the CE system. Each extraction
procedure was performed in triplicate.
2.4. Method validation
Because the entire DLLME optimization was performed in Czapek
liquid culture medium and because the fungal biotransformation
medium can present different characteristics due to the formation
of secondary fungi metabolites, the linearity of the method was
investigated in two different matrices: in Czapek liquid culture
medium and in a fungi pool that was prepared in the absence of
the analytes. The linearity of the method was assayed in triplicate.
The results were weighted by 1/x2 because the residual analysis of
the analytical curve exhibited heteroscedastic behavior. Analytical
curves (n¼3) were obtained by spiking aliquots of 1 mL of Czapek
liquid culture medium and the fungi pool with 50 mL each of
the HZ and CTZ enantiomers in the concentration range of 250–
12,500 ng mL1 and 125–6250 ng mL1, respectively. Linearity was
determined using the correlation coefﬁcient (r), the F test for lack-of-
ﬁt (FLOF), and a p value of 0.05. The programMINITAB Release version
14.1 (State College, PA, USA) was employed for statistical analysis. In
addition, the slopes of the different analytical curves that were
assayed in Czapek liquid culture medium and in the fungi pool were
analyzed and compared [27].
To determine the absolute recovery, aliquots of Czapek liquid
culture medium (1 mL) were spiked with CTZ at concentrations
of 250, 1250, and 5000 ng mL1 for each enantiomer (n¼3) and
with each HZ enantiomer (n¼3) at concentrations of 1000, 3000,
and 10,000 ng mL1 and submitted to the DLLME procedure. The
areas obtained for these samples were compared with the areas
achieved by the direct injection of pure solutions containing the
same amount of each compound dissolved in water. The recovery
was expressed as a percentage of the extracted amount.
The precision and accuracy of the method were assessed by the
within-day (n¼5) and between-day (n¼3) assays using 1 mL of
Czapek liquid culture medium spiked with each CTZ enantiomer at
concentrations of 125, 250, 1250, and 5000 ng mL1 and each HZ
enantiomer at concentrations of 250,1000, 3000, and 10,000 ngmL1.
The precision results were expressed as the relative standard deviation(RSD, %); the accuracy results were expressed in terms of percentage
accuracy according to the EMA guidelines [28].
The limit of quantiﬁcation was deﬁned as the lowest concen-
tration that could be determined with accuracy and precision
below 20% over ﬁve analytical runs, as recommended by the EMA
[28]. The determinations were carried out using Czapek liquid
culture medium (1 mL) spiked with 250 and 125 ng mL1 HZ and
CTZ, respectively.
The selectivity of the method was evaluated by analyzing
sterile Czapek liquid culture medium and sterile Czapek liquid
medium containing fungal mycelium under the previously estab-
lished conditions (see Section 2.6, “HZ biotransformation study”).
The freeze–thaw cycle stability, short-term room temperature
stability, and stability under the biotransformation conditions
were determined. To perform the freeze–thaw cycle stability
studies, three aliquots (n¼3) of the samples prepared in Czapek
liquid culture medium at concentrations of 250 and 5000 ng mL1
of each CTZ enantiomer and 1000 and 10,000 ng mL1 of each HZ
enantiomer were stored at 20 1C for 24 h, followed by thawing
at room temperature. Once completely thawed, the samples were
refrozen for 12 h under the same conditions. The freeze–thaw
cycle was repeated twice, and the samples were analyzed in
the third cycle. To determine the short-term room temperature
stability, aliquots of the samples prepared in liquid culture
medium at the concentrations speciﬁed above were kept at room
temperature (2272 1C) for 12 h and then analyzed. To determine
the stability under the biotransformation conditions, an aliquot
of 5 mg of HZ (free-base form) dissolved in 1 mL of sterile water
was added to an Erlenmeyer ﬂask containing 100 mL of Czapek
medium (25 μg mL1 of each enantiomer) and submitted to the
same conditions used in the biotransformation procedure (see
Section 2.6, “HZ biotransformation study”). During the biotrans-
formation period (15 days), aliquots of 1 mL (n¼3) were analyzed.
The stability of the samples placed in the CE auto-sampler was
evaluated. This procedure was performed using three aliquots
(n¼3) of samples prepared in Czapek liquid culture medium at
CTZ enantiomer concentrations of 250 and 5000 ng mL1 and HZ
enantiomer concentrations of 1000 and 10,000 ng mL1. The
samples were extracted and placed in the CE auto-sampler at
room temperature and analyzed after 24 h. The samples submitted
to the stability studies were considered stable if the relative error
(RE%) from the nominal concentration was within 715% and the
RSD was below 15%.
To investigate whether the resolution of the enantiomers
would change in the presence of different fungi, the relative standard
deviation (RSD%) and the resolution of the enantiomers were
determined separately in the presence of the following fungi:
Penicillium crustosum (VR4),Mucor rouxii NRRL 1894, Cunninghamella
echinulata var. elegans ATCC 8688A and Cunninghamella elegans ATCC
10028B (n¼3). The resolution values were determined by analyzing
the samples from the biotransformation study.
2.5. Fungi
The fungus Mucor rouxii NRRL 1894 was kindly provided by
Dr. C.W. Hesseltine (Northern Utilization Research and Develop-
ment Division, ARS, USDA, Peoria, IL, USA) and belonged to
a collection of fungal cultures of the Departamento de Biologia
da Faculdade de Filosoﬁa, Ciências e Letras de Ribeirão Preto,
University of São Paulo (FFCLRP/USP). The microorganism was
stored as a conidial suspension on silica gel (6–12 mesh, grade 40,
desiccant activated) at 4 1C and on slants of solid oatmeal baby
food consisting of 0.4% (w/v) oatmeal and 1.8% (w/v) agar.
The fungi Cunninghamella echinulata var. elegans ATCC 8688A
and Cunninghamella elegans ATCC 10028B were purchased from
the American Type Culture Collection (ATCC) (Manassas, VA, USA).
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(SS67) and Fusarium oxysporum (SS50) were previously isolated
as endophytes from the plant Smallanthus sonchifolius [29]; the
fungus Penicillium crustosum (VR4) was isolated from the plant
Viguiera robusta. The endophytic fungi and Cunninghamella strains
were maintained as potato dextrose agar plugs in 80% glycerol
(v/v) and stored at 20 1C in the Laboratório de Química de
Micro-organismos, FCFRP/USP, Brazil.
2.6. HZ biotransformation study
The biotransformation study was performed as previously
described by our group [30,31]. Three discs with 0.5-cm diameters
containing the fungal mycelia were aseptically transferred to 9.0-cm
diameter Petri dishes containing potato dextrose agar medium and
allowed them to grow for 7 days at 30 1C. Subsequently, three
uniform discs of 0.5-cm diameter of the fungus mycelia were
cut with a transfer tube (Fisher Scientiﬁc, Pittsburgh, PA, USA)
and inoculated in 50-mL Falcon tubes containing 20 mL of pre-
fermentative medium (10 g of malt extract, 10 g of dextrose, 5 g
of triptone, and 3 g of yeast extract and deionized water to 1 L;
the pH was adjusted to 6.2 with a solution of 0.5 mol L1 HCl).
The Falcon tubes were incubated for 7 days (168 h) at 30 1C on
a rotatory shaker (Cientec, CT712RN, SP, Brazil) operating at
125 rpm. Finally, the mycelium was completely transferred to
a 250-mL Erlenmeyer ﬂask containing 100 mL of Czapek liquid
culture medium (25.0 g of sucrose, 2.0 g of NaNO3, 1.0 g of KH2PO4,
0.5 g of MgSO4 7H2O, 0.5 g of KCl, 0.01 g of FeSO4 7H2O, and
deionized water to 1.0 L; pH adjusted to 5 with a solution of
1 mol L1 HCl). At this point, HZ (5 mg) was dissolved in 1 mL of
sterile water and added to the Czapek liquid culture medium.
The cultures were incubated for 360 h at 30 1C with shaking at
125 rpm. The three control ﬂasks consisted of (1) sterile Czapek
culture medium without HZ and the fungus, (2) sterile culture
medium with HZ and without the fungus, and (3) culture medium
with the fungal mycelium of the studied fungi and without HZ.
The CTZ enantiomeric excess (ee) following biotransformation
was determined by the equation ee¼(AB/A+B) 100, where A is
the peak area of the enantiomer present in higher concentration
and B is the peak area of the enantiomer present in lower
concentration [32]. The biotransformation kinetic studies were
presented as the concentration versus the collection interval
(hours). To assess the efﬁciency of the biotransformation process,
the amount of CTZ in the culture medium was quantiﬁed and
correlated with the initial amount of HZ (time 0). The biotrans-
formation procedure was performed in triplicate (n¼3).3. Results and discussion
3.1. Selection of the separation conditions
To achieve enantiomeric separation, we considered the physi-
cochemical properties of hydroxyzine (HZ, basic compound; pKa's
2.13 and 7.13) and cetirizine (CTZ, zwitterionic compound; pKa's
2.19, 2.93, and 8.0). Theoretically, CTZ can be considered a dication
at pHo2.19, a cation at a pH range from 2.19 to 2.93, a zwitterionic
compound at a pH range from 2.93 to 8.0, and an anion at
pH48.0. In turn, HZ can be considered a dication at pHo2.3, a
cation at a pH range from 2.13 to 7.13, and a neutral compound at
pH 7.13 [1].
We evaluated how pH affects the migration and separation
of the enantiomers at pH values of 8, 9, 10, 11, and 12 using a
50 mmol L1 sodium tetraborate solution containing S-β-CD (0.5%
w/v). In this pH range, HZ is in the neutral form, whereas CTZ and
S-β-CD are negatively charged. In this situation, electroosmoticﬂow induces the movement of the analytes toward the cathode.
We achieved the best resolution and suitable migration times
at pH 9.0, which was the pH value we selected for further
experiments.
We assessed the effect of the sodium tetraborate buffer (pH 9.0)
concentration in the range of 5–100 mmol L1 in the presence
of S-β-CD (0.5% w/v). The detection was optimal at buffer con-
centrations of 50 and 100 mmol L1, but 50 mmol L1 provided
superior resolution coupled with acceptable current levels, opti-
mal peak shape, and the lowest migration times. Hence, we
employed 50 mmol L1 in further experiments.
We investigated the efﬁciency of various chiral selectors using
CM-β-CD, S-β-CD, and HP-β-CD. S-β-CD was previously reported to
provide enantioselective resolution for CTZ enantiomers [5,19]; in
our experiments, S-β-CD was the only CD able to separate the CTZ
and HZ enantiomers. We examined the effects of S-β-CD concen-
tration on the enantioseparation using a 50 mmol L1 sodium
tetraborate buffer solution (pH 9.0) over a concentration range
of 0.5–1.0% (w/v) S-β-CD at an applied voltage of +10 kV. At
the highest S-β-CD concentration, we observed diminished and
improved HZ and CTZ enantiomer resolutions, respectively. The
S-β-CD concentration that afforded the best resolution for all the
analytes was 0.8% (w/v), which provided resolutions of 1.21 and
1.39 for the HZ and CTZ enantiomers, respectively.
We also optimized the capillary temperature and length. The
capillary temperature did not signiﬁcantly alter the CTZ or HZ
enantiomer resolution. With respect to the capillary length, the
analysis time decreased from 22 to 9 min by replacing a 40-cm
effective length with a 20-cm effective length capillary.
Therefore, the optimized conditions constituted a 50 mmol L1
sodium tetraborate buffer solution (pH 9.0) containing 0.8% (w/v)
S-β-CD and a voltage and temperature of +6 kV and 15 1C,
respectively. Under these conditions, we achieved suitable resolu-
tions (HZ enantiomers, Rs¼1.76; CTZ enantiomers, Rs¼1.52) in
9 min with an acceptable current level (E75 mA). Nojavan and
Fakhari [1] previously reported a method to enantioselectively
characterize HZ and CTZ by CE using maltodextrin as the chiral
selector and a 75 mmol L1 sodium phosphate solution (pH 2) as
the running buffer; under these conditions, the authors were able
to separate all the enantiomers in 33-min analytical runs. Deng
et al. [19] developed a method to analyze CTZ enantiomers and to
control the enantiomeric purity and the quality of (R)-CTZ in
pharmaceutical formulations. These authors also used S-β-CD as
the chiral selector and achieved a resolution of 3.1 with a mig-
ration time of 7 min. Despite the high resolution values achieved
by the aforementioned authors, we had difﬁculty separating the
HZ and CTZ enantiomers in a single run with a suitable resolution
and migration time. Increasing the S-β-CD concentration led to
improved CTZ enantiomer resolution; however, the HZ enantio-
mer resolution decreased dramatically. Thus, we found 0.8% (w/v)
S-β-CD to be the optimal chiral selector.
We determined the CTZ enantiomer migration order by injecting
a levocetirizine (R-CTZ) solution using the developed and validated
method. This analysis conﬁrmed that the second enantiomer to
migrate was (R)-CTZ, indicating that the ﬁrst enantiomer corre-
sponded to (S)-CTZ. Because we did not establish the HZ enantiomer
migration order, we simply designated the ﬁrst and second HZ
enantiomers to migrate as HZ (E1) and HZ (E2), respectively.
3.2. Development of the DLLME procedure
Various factors inﬂuence the extraction efﬁciency of the ana-
lytes by DLLME, such as the disperser and extraction solvent type
and volume, the extraction time, the centrifugation time, and
the extraction rate. Other frequently optimized parameters are the
salting-out effect and the pH of the sample [24,33]. However,
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previous knowledge about the neutral pH range for both analytes
[1] and considered salt addition unnecessary due to the large
amount of salt present in the matrix.
3.2.1. Effect of the disperser and extraction solvent type
An appropriate extraction solvent is the most important para-
meter when optimizing DLLME [23] because the organic solvents
used as the DLLME extraction solvent must be denser than water.
This density difference enables the separation of the extraction
solvent from the aqueous phase (matrix) by centrifugation.
We used chloroform, dichloromethane, and 1,1-dichloroethane to
investigate HZ and CTZ extraction from Czapek liquid culture
medium. In these experiments, we tested 200 mL of each extrac-
tion solvent and a ﬁxed volume of 500 mL of acetone (disperser
solvent used in this stage). According to Fig. 2A, dichloromethane
provided larger peak area responses for the HZ enantiomers,
whereas chloroform produced the highest peak area responses
for the CTZ enantiomers. The latter solvent was selected for
further experiments.
The solubility of the disperser solvent in the extraction solvent
and in the aqueous phase determines the choice of disperser,
which inﬂuences the generation of ﬁne droplets of the extraction
solvent in the aqueous phase [34]. Therefore, we evaluated acetone,
acetonitrile, methanol, and ethanol as disperser solvents. We
performed the experiments using 500 mL of each disperser solvent
and 200 mL of the optimized extraction solvent (chloroform). Fig. 2B
reveals that acetonitrile furnished higher peak area responses for
the HZ enantiomers, while methanol and ethanol produced better
responses for the CTZ enantiomers. Ultimately, ethanol was selected
as the disperser solvent due to its lower toxicity.
3.2.2. Effect of the extractor and disperser solvent volumes
To evaluate the effect of the extraction solvent volume on the
extraction efﬁciency, we subjected a constant ethanol volumeFig. 2. DLLME optimization. Selection of extraction solvent type (A), disperser solvent
extraction of HZ and CTZ enantiomers from Czapek culture medium. Extraction efﬁci
3000 rpm. The bars denote the standard deviation of replicate (n¼3).(400 mL) containing different volumes of chloroform (100–500 mL)
to the same DLLME procedure. Fig. 2C reveals higher peak areas
for the CTZ and HZ enantiomers when 300 mL of chloroform
was employed, which was the extraction solvent volume selected
for subsequent experiments. The disperser solvent volume affects
the formation of the cloudy state. To investigate this effect, we
evaluated the disperser solvent volume in the range of 300–700 mL
(Fig. 2D) using 300 mL of chloroform (extraction solvent). At low
ethanol volumes, we observed low extraction recoveries, most
likely because the cloudy solution was not well-formed. At high
ethanol volumes, the solubility of the analytes in the aqueous
phase increased, decreasing the extraction efﬁciency. We selected
an ethanol volume of 400 mL, which furnished the highest
recoveries.3.2.3. Effect of extraction time
The extraction time is deﬁned as the interval between the
injection of the disperser solvent and the extraction solvent
mixture and centrifugation [20]. According to several studies
[23,33], the extraction time affects the extraction efﬁciency in
DLLME to a small extent. This effect occurs because the surface
area between the extraction solvent and the aqueous phase
(sample) is inﬁnitely large. Hence, the transfer of the analytes
from the aqueous phase to the extraction phase is rapid (a few
seconds) [20]. Furthermore, the use of ultrasound (US) and vortex
(VX) improves the extraction efﬁciencies in DLLME [35,36]. Thus,
we evaluated assisted DLLME by comparing ultrasound-assisted
DLLME for 5 min, vortex-assisted DLLME for 30 s, and the combi-
nation of these two forms of assisted DLLME extraction. The
cloudy solution (CS) in combination with vortex agitation was
able to more efﬁciently extract HZ and CTZ than the ultrasound-
assisted method, most likely because the mechanical and thermal
effects of the ultrasound treatment resulted in the loss of the
volatile extraction solvent [35]. Moreover, fast vortex agitation
most likely broke the chloroform into ﬁne droplets, which moretype (B), extraction solvent volume (C) and disperser solvent volume (D) on the
encies represented by peak areas. Sample pH 7.5 and 5 min of centrifugation at
Fig. 3. Representative electropherograms of the enantioselective analysis of HZ and CTZ in Czapek culture medium after DLLME extraction. (A) Czapek culture medium
spiked with (1) internal standard, (2) E1-HZ and (3) E2-HZ (7500 ng mL1), (4) (S)-CTZ and (5) (R)-CTZ (2500 ng mL1). (B) Drug-free Czapek culture medium.
Electrophoretic and DLLME conditions are described in Sections 2.2 and 2.3, respectively.
Table 1
Linearity of the method for analysis of the analytes in Czapek liquid culture medium and in a fungi pool.
Analytes Type of matrix Linear equationa rb Ratio of slopes ANOVA lack-of-ﬁt
F-value p-value
(1)-HZ Fungi pool y¼0.000157x+0.0042 0.998 0.93 1.17 0.371
(1)-HZ Czapek medium y¼0.000169x+0.0101 0.998 0.77 0.585
(2)-HZ Fungi pool y¼0.000154x+0.0013 0.999 0.90 1.32 0.312
(2)-HZ Czapek medium y¼0.000171x+0.0124 0.998 1.39 0.288
(S)-CTZ Fungi pool y¼0.000243x+0.0035 0.999 1.00 2.86 0.055
(S)-CTZ Czapek medium y¼0.000242x+0.0024 0.998 2.66 0.068
(R)-CTZ Fungi pool y¼0.000243x+0.0030 0.997 1.05 1.78 0.181
(R)-CTZ Czapek medium y¼0.000232x+0.0045 0.998 1.90 0.159
a Three replicates (n¼3) for each concentration. Range: HZ¼250–12,500 ng mL1; CTZ¼125–6250 ng mL1.
b Correlation coefﬁcient.
Table 2
Limit of quantiﬁcation and recovery values of the method.
Analyte Nominal
concentration
(ng mL1)
Obtained
concentration
(ng mL1)
Accuracy Precision Recovery
% RSD (%)a % RSD
(%)a
(1)-HZ 250 231.7 92.6 11 90 7
(2)-HZ 250 241.4 96.5 10 91 5
(S)-CTZ 125 137.2 109.7 7 87 4
(R)-CTZ 125 136.7 109.3 7 87 6
a Relative standard deviation in percentage.
S.S. Fortes et al. / Talanta 116 (2013) 743–752748efﬁciently dispersed the droplets within the aqueous solution
[36,37]. As a result, vortexing provided enhanced mass transfer
and extraction efﬁciency.
3.2.4. Centrifugation parameters
Following vortex agitation, it was necessary to centrifuge the
cloudy solution to guarantee complete separation of the organic
and aqueous phases. We evaluated centrifugation times from 5 to
15 min at a ﬁxed rotation and temperature of 3000 rpm and 10 1C,
respectively. We selected a 5 min centrifugation time for subse-
quent experiments because no appreciable improvement in the
recovery was observed with longer centrifugation periods. Fig. 3
displays the electropherograms following the DLLME optimization.
The ﬁnal conditions for the DLLME consisted of ethanol (400 μL) as
the disperser solvent and chloroform (300 μL) as the extraction
solvent, followed by vortex agitation at 2000 rpm for 30 s. The
samples were then centrifuged at 3000 rpm for 5 min, and the
extraction solvent was sedimented to the bottom of the conical
glass tube for further analysis.
3.2.5. Method validation
We validated the CE method according to the EMA guidelines
[28]. We performed regression analyses by plotting the peak
area ratio of the analytes and I.S. versus the theoretical analyte
concentration. The method proved to be linear (Table 1) over the
concentration range of 125–6250 ng mL1 for each CTZ enantio-
mer and 250–12,500 ng mL1 for each HZ enantiomer; thecorrelation coefﬁcient was above 0.998, and the relative error for
each point of the analytical curves was below 15%. The slopes of
the analytical curves prepared in different matrices differed by less
than 10%, which indicated that the interferents present in the
fungi pool did not signiﬁcantly affect the DLLME procedure
[27,28,38]. In addition, we submitted the constructed analytical
curves to the ANOVA lack of ﬁt test and demonstrated their
validity (Table 1). The matrix did not inﬂuence the analyte
recovery; hence, we conducted the entire method validation
in Czapek liquid culture medium, which does not produce any
biological residues.
The mean (E1)-HZ, (E2)-HZ, (S)-CTZ, and (R)-CTZ recoveries were
90, 92, 87, and 87, respectively, with RSDs below 7%. The lowest
concentrations that the validated method was able to quantify were
Table 3
Precision and accuracy of the method.
Analyte Nominal concentration
(ng mL1)
Within-day (n¼5)a Between-day (n¼3)b
Concentration (ng mL1) RSD c (%) accuracy (%) Concentration (ng mL1) RSDc (%) accuracy (%)
(1)-HZ 250 255.6 2 102.2 245.5 5 98.2
1000 1092.2 3 109.2 1043.8 7 104.3
3000 3144.8 2 104.8 3231.6 2 107.7
10,000 9847.6 4 98.4 9724.1 6 97.2
(2)-HZ 250 258.2 6 103.2 248.3 5 99.32
1000 996.7 5 99.6 1008.9 8 100.8
3000 3101.6 1 103.3 3163.5 2 105.4
10,000 9759.3 2 97.5 9292.1 4 92.9
(S)-CTZ 125 120.5 4 96.4 125.9 8 100.7
250 249.4 5 99.7 255.0 5 102
1250 1200.3 3 96.0 1211.5 7 96.9
5000 4940.6 2 98.8 5065.4 6 101.3
(R)-CTZ 125 127.1 5 101.6 129.8 5 103.8
250 233.3 5 93.3 238.0 6 95.2
1250 1215.5 3 97.2 1215.1 5 97.2
5000 4904.8 2 98.0 5031.7 9 100.6
a Number of replicates.
b Number of days.
c Relative standard deviation in percentage.
Table 4
Freeze-thaw and short-term room temperature stability of HZ and CTZ enantiomers in Czapek culture medium.
Analyte (1)-HZ (2)-HZ (S)-CTZ (R)-CTZ
Stability
Freeze-thaw cycles (n¼3)
Concentration (ng mL1) 243.2 8914.0 236.0 9073.4 225.2 4386.8 232.7 4471.2
Precision (RSD)a 1 7 1 6 4 6 2 7
Accuracy (RE, %)b 2.7 10.8 5.5 9.2 9.8 12.2 6.8 10.5
Short-term (n¼3)
Concentration (ng mL1) 242.2 8714.3 233.1 8706.2 238.8 4719.7 234.5 4603.5
Precision (RSD)a 1 8 3 7 3 5 2 3
Accuracy (RE, %)b 3.1 12.8 6.7 12.9 4.4 5.6 6.1 7.9
n¼number of determinations.
a Expressed as relative standard deviation, RSD (%).
b Expressed as relative error, RE (%).
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(Table 2). We assessed the precision and accuracy of the method for
both within-day (ﬁve spiked Czapek culture medium samples for each
concentration on the same day) and between-day (ﬁve spiked Czapek
culture medium samples for each concentration for three consecutive
days) determinations (Table 3). The RSDs were under 15%, and the
accuracy values were within 15% of the nominal values.
The HZ and CTZ freeze-thaw and short-term room temperature
stability in Czapek culture medium revealed RSDs of less than 15%,
and the RE% from the nominal concentrations fell within715%
(Table 4). CTZ and HZ were stable in the auto sampler for 24 h and
for 360 h under the biotransformation conditions (RSDo15% and
RE %715%); we veriﬁed that no CTZ or HZ degradation occurred
during this period (data not shown). The selectivity of the separa-
tion was high, as the studied fungus did not produce any
secondary metabolites with migration times close to those of the
HZ and CTZ enantiomers (Fig. 4). Moreover, the Czapek liquid
culture medium did not present any interfering peaks (data not
shown).
The investigation of the resolution values in different fungal
biotransformation media and in a pure Czapek medium revealed
that the type of fungus can inﬂuence the resolution value of
the enantiomers (Table 5). This effect can be attributed to the
difference in the ionic strengths of the culture media, which can
lead to an anti-stacking effect [39] that affects the resolution of theenantiomers. Although the composition of the culture medium
was the same for all the evaluated fungi (Czapek medium), the
consumption of salts by the fungi can differ during the biotrans-
formation period, leading to differences in the culture medium
composition.
3.3. HZ biotransformation study
The monitored HZ biotransformation involves a carboxylation
reaction that yields the active metabolite CTZ. We selected fungi
belonging to the genus Cunninghamella because they had been
previously shown to perform carboxylation reactions on various
drugs, including celecoxib [40], ebastine [41], and muraglitazar
[42]. Our group also veriﬁed other classes of oxidation reaction for
these fungi; using the fungi M. rouxii, N. sphaerica, F. oxysporum,
and P. crustosum, we observed a sulfoxidation reaction for the drug
albendazole [9,30]. The fungus P. crustosum also performed a
sulfoxidation of the drug thioridazine [15]; furthermore, it was
able to biotransform the drugs propranolol [43] and ibuprofen [44]
via a hydroxylation reaction. We also reported that the fungus
M. rouxii performed hydroxylation during risperidone biotransfor-
mation [14].
We followed the HZ biotransformation for 15 days (360 h). Aliquots
were collected every 48 h until day 10 and then again on day 15.
We analyzed the collected samples by CE using a simultaneously
Fig. 4. (A) Representative electropherograms for 360-h HZ incubation with the studied fungi (B) Czapek culture medium incubated with the studied fungi (fungus control)
showing that these fungi did not produce any secondary metabolite in the migration time of the analytes. (1) internal standard, (2) E1-HZ, (3) E2-HZ, (4) (S)-CTZ and (5) (R)-CTZ.
Electrophoretic and DLLME conditions are described in Sections 2.2 and 2.3, respectively.
Table 5
Resolution values for different fungal biotransformation media.
Medium HZ resolution (RSD%) CTZ resolution (RSD%)
Czapek liquid medium 1.76 (1.5) 1.52 (0.3)
Fungus 10028B 1.55 (5.9) 1.52 (3.1)
Fungus VR4 1.78 (3.9) 1.70 (7.3)
Fungus 8688A 1.77 (5.4) 1.50 (4.0)
Fungus Mucor rouxii 2.52 (0.79) 1.47 (0.8)
RSD, relative standard deviation in percentage (n¼3).
S.S. Fortes et al. / Talanta 116 (2013) 743–752750obtained calibration curve. Following the extraction and analysis, we
determined the analyte concentrations and plotted the concentration
as a function of the incubation time. The fungi SS50 and SS67 did not
biotransform HZ under the evaluated conditions. The fungus VR4 did
not afford a good biotransformation yield; CTZ enantiomers were only
detected after 360 h of incubation (data not shown). The fungus
Cunninghamella elegans ATCC 8688 A produced the highest (S)-CTZ
yield: at 96 h of incubation, only (S)-CTZ was present in the culture
medium (Fig. 4), and at 144 h, (R)-CTZ was also present. At 360 h, the
maximum (S)-CTZ and (R)-CTZ concentrations in the culture medium
were 12,270 and 6277 ngmL1, respectively (57 and 26% biotransfor-
mation, respectively, Fig. 5A), corresponding to a (S)-CTZ ee of 32%. HZbiotransformation by the fungus C. elegans ATCC 10028B resulted in
predominantly (S)-CTZ formation (Fig. 4). The CTZ enantiomer pro-
duction began after 96 h of incubation. At 360 h, the maximal CTZ
enantiomer concentrations in the culture medium were 2693 and
579 ngmL1 (19 and 4% biotransformation, respectively) for (S)-CTZ
and (R)-CTZ, respectively (Fig. 5B), which corresponded to a (S)-CTZ ee
of 65%.
The biotransformation of HZ by the soil fungus Mucor rouxii
NRRL 1894 resulted in the predominant formation of the S- enantio-
mer of CTZ (Fig. 4). After 360 h of incubation, the maximal (S)-CTZ
and (R)-CTZ concentrations in the culture medium were 1957 and
495 ng mL1, respectively (7 and 2% of biotransformation, respec-
tively, Fig. 5C), which corresponded to a (S)-CTZ ee of 60%.4. Conclusion
This study demonstrated the successful use of DLLME–CE to
enantioselectively determine HZ and CTZ in a complex matrix. The
assessed validation parameters met the literature requirements
[28]. This method constitutes the ﬁrst report of simultaneous
HZ and CTZ extraction by DLLME, which is a powerful tool for
studying HZ fungal biotransformation. In comparison with other
Fig. 5. Concentration-time proﬁles for the biotransformation of HZ by the fungi (A) Cunninghamella echinulata var. elegans ATCC 8688A, (B) Cunninghamella elegans ATCC
10028B, and (C) Mucor rouxii NRRL 1894. The bars denote the standard deviation of replicate (n¼3). (●) E1-HZ, (■) E2-HZ, (○)-CTZ and (□) (R)-CTZ.
S.S. Fortes et al. / Talanta 116 (2013) 743–752 751literature methods, DLLME-CE offers the following advantages:
(i) shorter analysis times compared with the procedure described
by Nojavan et al. [1] and (ii) a simpler extraction procedure as wellas lower solvent consumption in comparison with the previously
described protein precipitation [16–18] and LLE [1,5] procedures.
Moreover, the recovery was signiﬁcantly improved in our DLLME
S.S. Fortes et al. / Talanta 116 (2013) 743–752752procedure through the addition of a vortex-assisted step relative
to the cloudy solution only. In addition, this is the ﬁrst report of
the enantioselective HZ biotransformation to CTZ with predomi-
nant (S)-CTZ formation.Acknowledgments
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